Beacon Clinical Research

Quincy, Massachusetts 02169

1 studies enrolling now · 6 studies all time

What they study most

Atopic Dermatitis, Motion Sickness, Netherton Syndrome, Overactive Bladder, Type 2 Diabetes Mellitus

Studies at this site

• Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome — Recruiting now
• POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis — Completed
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) — Completed
• Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed